Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

2317-2328 of 2541 results
Page 194 of 212
Key Publications February 8, 2016

Requiem for the 'vulnerable plaque'.

Eur Heart J. 2015;36:2984-7

Libby P, Pasterkamp G
Acute Coronary Syndromes Cardiovascular Disease Inflammation
Key Publications February 8, 2016

Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study.

Lancet. 2015;386:1945-1954

Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP et al.
Cancer Cardiovascular Disease Nutrition
Key Publications February 8, 2016

Metabolic dyslipidemia and risk of coronary heart disease in 28,318 adults with diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.

Am J Cardiol. 2015;116:1700-4

Rana JS, Liu JY, Moffet HH, Solomon MD, Go AS, Jaffe MG, Karter AJ
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications February 5, 2016

Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: a LIFE substudy.

J Hypertens. 2015;33:2422-30

Vishram JK, Dahlöf B, Devereux RB, Ibsen H, Kjeldsen SE, Lindholm LH, Mancia G, Okin PM, Rothwell PM, Wachtell K, Olsen MH
Cardiometabolic Risk Cardiovascular Disease Hypertension
Key Publications February 4, 2016

Epicardial adipose tissue thickness can be used to predict major adverse cardiac events.

Coron Artery Dis. 2015;26:686-91

Tanindi A, Erkan AF, Ekici B
Cardiovascular Disease Diabetes Ectopic Fat
Key Publications February 4, 2016

Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: A meta-analysis and systematic review.

Circulation. 2015;132:1795-804

Pan A, Wang Y, Talaei M, Hu FB
Cardiovascular Disease Diabetes Smoking
Key Publications February 3, 2016

Clinical application and potential effects of 2014 hypertension guidelines on incident cardiovascular events.

Am Heart J. 2015;170:1042-1049

Ko MJ, Park CM, Kim YJ, Kang SH, Park DW
Cardiovascular Disease Hypertension Prevention
Key Publications February 3, 2016

Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis.

Am Heart J. 2015;170:923-8

Brandon Stacey R, Leaverton PE, Schocken DD, Peregoy JA, Bertoni AG
Cardiovascular Disease Clinical Cardiology Insulin Resistance
Key Publications February 2, 2016

Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?

J Lipid Res. 2015;56:2045-7

Barter PJ, Tabet F, Rye KA
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications February 2, 2016

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9.

J Lipid Res. 2015;56:2085-93

van der Tuin SJ, Kühnast S, Berbée JF, Verschuren L, Pieterman EJ, Havekes LM, van der Hoorn JW, Rensen PC, Jukema JW, Princen HM, Willems van Dijk K, Wang Y
Cardiovascular Disease Lipids/Lipoproteins Metabolism: Human Studies
Key Publications February 1, 2016

Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals.

Lancet. 2015;386:1739-46

Kivimäki M, Jokela M, Nyberg ST, Singh-Manoux A, Fransson EI, Alfredsson L et al.
Cardiometabolic Risk Cardiovascular Disease Epidemiology
Key Publications February 1, 2016

Incident diabetes mellitus, hypertension, and cardiovascular disease risk in exercising hypercholesterolemic patients.

Am J Cardiol. 2015;116:1516-20

Williams PT, Franklin BA
Cardiovascular Disease Diabetes Hypertension
of 212